Structure-activity relationships of Toxoplasma gondii cytochrome bc1 inhibitors
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 9, 2022 Category: Drugs & Pharmacology Authors: P. Holland Alday Aaron Nilsen J. Stone Doggett Source Type: research

Reinforcement learning for systems pharmacology-oriented and personalized drug design
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 5, 2022 Category: Drugs & Pharmacology Authors: Ryan K. Tan Yang Liu Lei Xie Source Type: research

The impact of machine learning on future tuberculosis drug discovery
Volume 17, Issue 9, September 2022, Page 925-927 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 3, 2022 Category: Drugs & Pharmacology Authors: David A. Winkler Source Type: research

The impact of machine learning on future tuberculosis drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - August 3, 2022 Category: Drugs & Pharmacology Authors: David A. Winkler Source Type: research

The piperazine scaffold for novel drug discovery efforts: the evidence to date
Volume 17, Issue 9, September 2022, Page 969-984 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 29, 2022 Category: Drugs & Pharmacology Authors: Maria Novella Romanelli Dina Manetti Laura Braconi Silvia Dei Alessio Gabellini Elisabetta Teodori Source Type: research

The piperazine scaffold for novel drug discovery efforts: the evidence to date
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 29, 2022 Category: Drugs & Pharmacology Authors: Maria Novella Romanelli Dina Manetti Laura Braconi Silvia Dei Alessio Gabellini Elisabetta Teodori Source Type: research

Combinatorial approaches for novel cardiovascular drug discovery: a review of the literature
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 27, 2022 Category: Drugs & Pharmacology Authors: Simone Brogi Rita Tabanelli Vincenzo Calderone Source Type: research

Novel avenues for identification of new antifungal drugs and current challenges
Volume 17, Issue 9, September 2022, Page 949-968 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 21, 2022 Category: Drugs & Pharmacology Authors: Josef Jampilek Source Type: research

Novel avenues for identification of new antifungal drugs and current challenges
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 21, 2022 Category: Drugs & Pharmacology Authors: Josef Jampilek Source Type: research

Acute radiation syndrome drug discovery using organ-on-chip platforms
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 19, 2022 Category: Drugs & Pharmacology Authors: Vijay K. Singh Thomas M. Seed Source Type: research

Drug design strategies for the treatment azole-resistant candidiasis
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 19, 2022 Category: Drugs & Pharmacology Authors: Setareh Moghimi Mohammad Shafiei Alireza Foroumadi Source Type: research

Industrializing AI-powered drug discovery: lessons learned from the Patrimony computing platform
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 11, 2022 Category: Drugs & Pharmacology Authors: Micka ël Guedj Jack Swindle Antoine Hamon Sandra Hubert Emiko Desvaux Jessica Laplume Laura Xuereb C éline Lefebvre Yannick Haudry Christine Gabarroca Audrey Aussy Laurence Laigle Isabelle Dupin-Roger Philippe Moingeon Source Type: research

Avenues for antifungal drug discovery and development: where to now?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - July 8, 2022 Category: Drugs & Pharmacology Authors: Stephanos Vassilopoulos Eleftherios Mylonakis Source Type: research

Lessons learned from the preclinical discovery and development of sarilumab for the treatment of rheumatoid arthritis
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - June 28, 2022 Category: Drugs & Pharmacology Authors: Gabriella Maioli Roberto Caporali Ennio Giulio Favalli Source Type: research